Showing 1 - 5 results of 5 for search 'Swayamjeet Satapathy', query time: 0.03s
Refine Results
-
1
-
2
A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastas... by Sivasankar Kanankulam Velliangiri, Sanjana Ballal, Madhav Prasad Yadhav, Madhavi Tripathi, Swayamjeet Satapathy, Chandrasekhar Bal
Published 2023-01-01
Article -
3
A long-term retrospective cohort-based risk-benefit analysis of augmenting total cumulative I-131 activity to 37GBq in differentiated thyroid cancer patients with skeletal metastas... by Sivasankar Kanankulam Velliangiri, Sanjana Ballal, Madhav Prasad Yadhav, Madhavi Tripathi, Swayamjeet Satapathy, Chandrasekhar Bal
Published 2023-01-01
Article -
4
177Lu-DOTATATE Plus Radiosensitizing Capecitabine Versus Octreotide Long-Acting Release as First-Line Systemic Therapy in Advanced Grade 1 or 2 Gastroenteropancreatic Neuroendocrin... by Swayamjeet Satapathy, Bhagwant R. Mittal, Ashwani Sood, Apurva Sood, Rakesh Kapoor, Rajesh Gupta, Divya Khosla
Published 2021-12-01
Article -
5
Head-to-Head Comparison of SSTR Antagonist [<sup>68</sup>Ga]Ga-DATA<sup>5m</sup>-LM4 with SSTR Agonist [<sup>68</sup>Ga]Ga-DOTANOC PET/CT in Patients with Well Differentiated Gastr... by Rahul Viswanathan, Sanjana Ballal, Madhav P. Yadav, Frank Roesch, Parvind Sheokand, Swayamjeet Satapathy, Madhavi Tripathi, Shipra Agarwal, Euy Sung Moon, Chandrasekhar Bal
Published 2024-02-01
Article